Modulation of MMPs by cell surface integrin receptor α5β1

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 7, 2012, Pages 726-732

  Pal, Sekhar ^a   Ganguly, Kirat Kumar ^a   Moulik, Shuvojit ^a   Chatterjee, Amitava ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

ECM; Fibronectin; Integrin; MMP

Indexed keywords

FIBRONECTIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TYROSINE; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CULTURE; CELL MIGRATION; CELL SHAPE; CELL STRAIN MCF 7; CELL SURVIVAL; EXTRACELLULAR MATRIX; FIBROSARCOMA; GENE EXPRESSION; HUMAN; IN VITRO STUDY; LARYNX CARCINOMA; LUNG INJURY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER;

EID: 84866416031     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012802650183     Document Type: Article

References (88)

1. Kim, S.H.; Turnbull, J.; Guimond, S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol., 2011, 209, 139-151.
2. Berrier, A.L.; Yamada, K.M. Cell-matrix adhesion. J. Cell Physiol., 2007, 213(3), 565-573.
3. Akiyama, S.K.; Olden, K.; Yamada, K.M. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev., 1995, 14, 173-189.
4. Wayner, E.A.; Carter, W.G. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J. Cell Biol., 1987, 105, 1873-1884.
5. Charo, I.F.; Nannizzi, L.; Smith, J.W.; Cheresh, D.A. The vitronectin receptor αvβ3 binds fibronectin and acts in concert with α5β1 in promoting cellular attachment and spreading on fibronectin. J. Cell Biol., 1990, 111, 2795-2800.
6. Busk, M.; Pytela, R.; Sheppard, D. Characterization of the integrin αvβ6 as a fibronectin-binding protein. J. Biol. Chem., 1992, 267, 5790-5796.
7. Jiménez-Soto, L.F.; Kutter, S.; Sewald, X.; Ertl, C.; Weiss, E.; Kapp, U.; Rohde, M.; Pirch, T.; Jung, K.; Retta, S.F.; Terradot, L.; Fischer, W.; Haas, R. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog., 2009, 5(12), e1000684.
8. Geiger, B.; Bershadsky, A.; Pankov, R.; Yamada, K.M. Transmembrane crosstalk between the extracellular matrix and the cytoskeleton. Nat. Rev. Mol. Cell Biol. 2001, 2, 793-805.
9. Munshi, H.G.; Stack, M.S. Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev., 2006, 25(1), 45-56.
10. Ra, H.J.; Parks, W.C. Control of matrix metalloproteinase catalytic activity. Matrix Biol., 2007, 26(8), 587-596.
11. Springman, E.B.; Angleton, E.L.; Birkedal-Hansen, H.; Van Wart, H.E. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. U.S.A., 1990, 87, 364-368.
12. Rolli, M.; Fransvea, E.; Pilch, J.; Saven, A.; Felding-Habermann, B. Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 9482-9487.
13. Riikonen, T.; Westermarck, J.; Koivisto, L.; Broberg, A.; Kahari, V. M.; Heino, J. Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J. Biol. Chem., 1995, 270(22), 13548-13552.
14. Sen, T.; Dutta, A.; Maity, G.; Chatterjee, A. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. Biochimie, 2010, 92, 1422-1434.
15. Das, S.; Banerji, A.; Frei, E.; Chatterjee, A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci., 2008, 82, 467-476.
16. Kornberg, L.J.; Earp, H.S.; Turner, C.E.; Prockop, C.; Juliano, R.L. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins. Proc. Natl. Acad. Sci. USA, 1991, 88, 8392-8396.
17. Schaller, M.D.; Borgman, C.A.; Cobb, B.S.; Vines, R.R.; Reynolds, A.B.; Parsons, J.T. pp125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. U.S.A., 1992, 89, 5192-5196.
18. Hanks, S.K.; Calalb, M.B.; Harper, M.C.; Patel, S.K. Focal adhesion protein tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. USA, 1992, 89, 8487-8491.
19. Aplin, A.E.; Howe, A.; Alahari, S.K.; Juliano, R.L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev., 1998, 50, 197-263.
20. Parsons, J.T.; Martin, K.H.; Slack, J.K.; Taylor, J.M.; Weed, S.A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene, 2000, 19, 5606-5613.
21. Schaller, M.D. The focal adhesion kinase. J. Endocrinol., 1996, 150(1), 1-7.
22. Giancotti, F.G.; Ruoslahti, E. Integrin signaling. Science, 1999, 285, 1028-1032.
23. Segarra, M.; Vilardell, C.; Matsumoto, K.; Esparza, J.; Lozano, E., Serra-Pages, C.; Urbano-Márquez, A.; Yamada, K.M.; Cid, M.C. Dual function of focal adhesion kinase in regulating integrininduced MMP-2 and MMP-9 release by human T lymphoid cells. FASEB J., 2005, 19(13), 1875-1877.
24. Maity, G.; Choudhury, P.R.; Sen, T.; Ganguly, K.K.; Sil, H.; Chatterjee, A. Culture of human breast cancer cell line (MDAMB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol., 2011, 32, 129-138.
25. Wei, Y.; Tang, C.H.; Kim, Y.; Robillard, L.; Zhang, F.; Kugler, M.C.; Chapman, H.A. Urokinase receptors are required for α5β1 integrin-mediated signaling in tumor cells. J. Biol. Chem., 2007, 282(6), 3929-3939.
26. Wilson, S.H.; Ljubimov, A.V.; Morla, A.O.; Caballero, S.; Shaw, L.C.; Spoerri, P.E.; Tarnuzzer, R.W.; Grant, M.B. Fibronectin fragments promote human retinal endothelial cell adhesion and proliferation and ERK activation through α5β1 integrin and PI 3- kinase. Invest. Ophthalmol. Vis. Sci., 2003, 44, 1704-1715.
27. Lin, T.H.; Aplin, A.E.; Shen, Y.; Chen, Q.; Schaller, M.; Romer, L.; Aukhil, I.; Juliano, R.L. Integrin mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J. Cell Biol., 1997, 136, 1385-95.
28. Wary, K.K.; Mariotti, A.; Zurzolo, C.; Giancotti, F.G. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell, 1998, 94, 625-634.
29. Wei, Y.; Yang, X.; Liu, Q.; Wilkins, J.A.; Chapman, H.A. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J. Cell Biol., 1999, 144, 1285-1294.
30. Howe, A.K.; Juliano, R.L. Distinct mechanisms mediate the initial and sustained phases of integrin-mediated activation of the Raf/MEK/mitogen activated protein kinase cascade. J. Biol. Chem., 1998, 273, 27268-27274.
31. Miranti, C.K.; Ohno, S.; Brugge, J.S. Protein kinase C regulates integrin induced activation of the extracellular regulated kinase pathway upstream of Shc. J. Biol. Chem., 1999, 274, 10571-10581.
32. Cox, E.A.; Sastry, S.K.; Huttenlocher, A. Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases. Mol. Biol. Cell., 2001, 12, 265-277.
33. Maekawa, M.; Ishizaki, T.; Boku, S.; Watanabe, N.; Fujita, A.; Iwamatsu, A.; Obinata, T.; Ohashi K.; Mizuno, K.; Narumiya, S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science, 1999, 285, 895-898.
34. Edwards, D.C.; Sanders, L.C.; Bokoch, G.M.; Gill, G.N. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signaling to actin cytoskeletal dynamics. Nat. Cell Biol., 1999, 1, 253-259.
35. Ren, X. D.; Kiosses, W.B.; Sieg, D.J.; Otey, C.A.; Schlaepfer, D.D.; Schwartz, M.A. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J. Cell Sci., 2000, 113, 3673-3678.
36. Arthur, W.T.; Petch, L.A.; Burridge, K. Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Curr. Biol., 2000, 10, 719-22.
37. Treisman, R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol., 1996, 8(2), 205-215.
38. Ip, Y.T.; Davis, R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. Curr. Opin. Cell. Biol., 1998, 10, 205-219.
39. Dolfi, F.; Garcia-Guzman, M.; Ojaniemi, M.; Nakamura, H.; Matsuda, M.; Vuori, K. The adaptor protein Crk connects multiple cellular stimuli to the JNK signaling pathway. Proc. Natl. Acad. Sci. USA., 1998, 95(26), 15394-15399.
40. Miyamoto, S.; Teramoto, H.; Coso O.A.; Gutkind J.S.; Burbelo P.D.; Akiyama, S.K.; Yamada, K.M. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol., 1995, 131(3), 791-805.
41. Oktay, M.; Wary, K.K.; Dans, M.; Birge, R.B.; Giancotti, F.G. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J. Cell Biol., 1999, 145(7), 1461-1469.
42. Lopez-Bergami, P.; Huang, C.; Goydos, J.S.; Yip, D.; Bar-Eli, M.; Herlyn, M.; Smalley, K. S.; Mahale, A.; Eroshkin, A.; Aaronson, S.; Ronai, Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell., 2007, 11(5), 447-460.
43. Frisch, S.M.; Vuori, K.; Ruoslahti, E.; Chan-Hui, P.Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol., 1996,134(3), 793-799.
44. Hungerford, J.E.; Compton, M.T.; Matter, M.L.; Hoffstrom, B.G.; Otey, C.A. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J. Cell Biol., 1996, 135, 1383-1390.
45. Ilić, D.; Almeida, E.A.C.; Schlaepfer, D.D.; Dazin, P.; Aizawa, S.; Damsky, C.H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol., 1998, 143, 547-560.
46. Kane, L.P.; Shapiro, V.S.; Stokoe, D.; Weiss, A. Induction of NF- κB by the Akt/PKB kinase. Curr. Biol., 1999, 9, 601-604.
47. Maity, G.; Fahreen, S.; Banerji, A.; Roychoudhury, P.; Sen, T.; Dutta, A.; Chatterjee, A. Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa). Mol. Cell Biochem., 2010, 336, 65-74.
48. Chon, J.H.; Netzel, R.; Rock, B.M.; Chaikof, E.L. α4β1 and α5β1 control cell migration on fibronectin by differentially regulating cell speed and motile cell phenotype. Ann. Biomed. Eng., 1998, 26, 1091-1101.
49. Zervos, E.E.; Shafii, A.E.; Haq, M.; Rosemurgy, A.S. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro. J. Surg. Res., 1999, 84, 162-7.
50. Overall, C. M.; López-Otín, C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer, 2002, 2, 657-672.
51. Mitra, A.; Chakrabarti, J.; Banerji, A.; Chatterjee, A.; Das, B.R. Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J. Environ. Pathol. Toxicol. Oncol., 2006,25, 679-690.
52. Yoshizaki, T.; Sato, H.; Furukawa, M. Recent advances in the regulation of matrix metalloproteinase 2 activation: from basic research to clinical implication (Review). Oncol. Rep., 2002, 9(3), 607-611.
53. Sandya, S.; Achan, M.A.; Sudhakaran, P.R. Multiple matrix metalloproteinases in type II collagen induced arthritis. Indian J. Clin. Biochem. 2009, 24, 42-48.
54. Swarnakar, S.; Ganguly, K.; Kundu, P.; Banerjee, A.; Maity, P.; Sharma, A.V. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin induced gastric ulcer. J. Biol. Chem., 2005, 280, 9409-9415.
55. Morozevich, G.; Kozlova, N., Cheglakov, I.; Ushakova, N.; Berman, A. Integrin α5β1 controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity. Cell Cycle., 2009, 8, 2219-2225.
56. Morozevich, G.E.; Kozlova, N.I.; Cheglakov, I.B.; Ushakova, N.A.; Preobrazhenskaya, M.E.; Berman, A.E. Implication of α5β1 integrin in invasion of drug-resistant MCF-7/ADR breast carcinoma cells: a role for MMP-2 collagenase. Biochemistry (Mosc), 2008, 73, 791-796.
57. Mitra, A.; Chakrabarti, J.; Chatterjee, A. Binding of α5 monoclonal antibody to cell surface α5β1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells. J. Environ. Pathol Toxicol. Oncol., 2003, 22, 167-178.
58. Stanton, H.; Gavrilovic, J.; Atkinson, S.J.; d'Ortho, M.P.; Yamada, K.M.; Zardi, L.; Murphy, G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J. Cell Sci., 1998, 111, 2789-2798.
59. Kenny, H.A.; Kaur, S.; Coussens, L.M.; Lengyel, E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest., 2008, 118, 1367-1379.
60. Pöllänen, J.; Hedman, K.; Nielsen, L.S.; Danø, K.; Vaheri, A. Ultrastructural localization of plasma membrane-associated urokinase type plasminogen activator at focal contacts. J. Cell Biol., 1988, 106, 87-95.
61. Aggeler, J.; Frisch, S.M.; Werb, Z. Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts. J. Cell Biol., 1984, 98, 1662-1671.
62. Werb, Z.; Hembry, R.M.; Murphy, G.; Aggeler, J. Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: Relationship of inducing events to changes in cytoskeletal architecture. J. Cell Biol., 1986, 102, 697-702.
63. Terranova, V.P.; Williams, J.E.; Liotta, L.A.; Martin, G.R. Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science, 1984, 226, 982-985.
64. Stack, S.; Gray, R.D.; Pizzo, S.V. Modulation of plasminogen activation and type IV collagenase activity by a synthetic peptide derived from the laminin A chain. Biochemistry, 1991, 30, 2073-2077.
65. Xie, Z.; Singh, M.; Singh, K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1β. J Biol Chem., 2004, 279, 39513-39519.
66. Hofmann, U.B.; Westphal, J.R.; Waas, E.T.; Becker, J.C.; Ruiter, D.J.; van Muijen, G.N.P. Coexpression of integrin αvβ3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. J. Invest. Dermatol., 2000, 115, 625-632.
67. Tokuraku, M.; Sato, H.; Murakami, S.; Okada, Y.; Watanabe, Y.; Seiki, M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MTMMP) and with lymph node metastasis. Int. J. Cancer, 1995, 64, 355-359.
68. Kurschat, P.; Zigrino, P.; Nischt, R.; Breitkopf, K.; Steurer, P.; Klein, C.E.; Krieg, T.; Mauch, C. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J. Biol. Chem., 1999, 274, 21056-21062.
69. Lehti, K.; Lohi, J.; Valtanen, H.; Keshi-oja, J. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with Gelatinase A activation at the cell surface. Biochem. J., 1998, 334, 345-353.
70. Jo, Y.; Yeon, J.; Kim, H.J.; Lee, S.T. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Biochem. J., 2000, 345, 511-519.
71. Kozlova, N.I.; Morozevich, G.E.; Chubukina, A.N.; Shtil, A.A.; Berman, A.E. Expression of integrins, anchorage dependent apoptosis and invasiveness of multidrug resistant human breast carcinoma cells. EXCLI. J., 2004, 3, 68-81.
72. Dutta, A.; Sen, T.; Chatterjee, A. Culture of K562 human myeloid leukemia cells in presence of fibronectin expresses and secretes MMP-9 in serum-free culture medium. Int. J. Clin. Exp. Pathol., 2010, 3, 288-302.
73. Hartney, J.M.; Brown, J.; Chu, H.W.; Chang, L.Y.; Pelanda, R.; Torres, R.M. Arhgef1 regulates α5β1 integrin-mediated matrix metalloproteinase expression and is required for homeostatic lung immunity. Am. J. Pathol., 2010, 176, 1157-1168.
74. Xie, B.; Laouar, A.; Huberman, E. Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation: The signaling role of protein kinase C-β. J. Biol. Chem., 1998, 273, 11576-11582.
75. Martin, J.; Eynstone, L.; Davies, M.; Steadman, R. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J. Am. Soc. Nephrol., 2001, 12, 88-96.
76. Murray, G.I.; Duncan, M.E.; O'Neil, P.; Melvin, W.T.; Fothergill, J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med, 1996, 2, 461-462.
77. Murray, G. I.; Duncan, M.E.; O'Neil, P.; McKay, J.A.; Melvin, W.T.; Fothergill, J.E. Matrix metalloproteinase-1 is associated withpoor prognosis in oesophageal cancer. J. Pathol, 1998, 185, 256-261.
78. Shiozawa, J.; Ito, M.; Nakayama, T.; Nakashima, M.; Kohno, S.; Sekine, I. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod. Pathol., 2000, 13, 925-933.
79. Jia, Y., Zeng, Z.Z.; Markwart, S.M.; Rockwood K.F.; Ignatoski, K.M.W.; Ethier, S.P.; Livant, D.L. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Res., 2004, 64, 8674-8681.
80. Zeng, Z.Z.; Jia, Y.; Hahn, N.J.; Markwart, S.M.; Rockwood, K.F.; Livant, D.L. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res., 2006, 66, 8091-8099.
81. Zeisel, M.B.; Druet, V.A.; Wachsmann, D.; Sibilia, J. MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin α5β1. Arthritis Res. Ther., 2005, 7, R118-R126.
82. Homandberg, G.A.; Costa, V.; Wen, C. Fibronectin fragments active in chondrocytic chondrolysis can be chemically cross-linked to the α5 integrin receptor subunit. Osteoarthritis Cartilage, 2002, 10, 938-949.
83. Xie, D.L.; Hui, F.; Meyers, R.; Homandberg, G.A. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Arch. Biochem. Biophys., 1994, 311, 205-212.
84. DiPersio, C.M.; Shao, M.; Di Costanzo, L.; Kreidberg, J.A.; Hynes, R.O. Mouse keratinocytes immortalized with large T antigen acquire α3β1 integrin-dependent secretion of MMP-9/gelatinase B. J. Cell Sci., 2000, 113, 2909-2921.
85. Iyer, V.; Pumiglia, K.; Di Persio, C.M. α3β1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression. J. Cell Sci., 2005, 118, 1185-1195.
86. Stricker, T.P.; Dumin, J.A.; Dickeson, S.K.; Chung, L.; Nagase, H, Parks W.C.; Santoro, S.A. Structural analysis of the α2 integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J. Biol. Chem., 2001, 276, 29375-29381.
87. Nisato, R.E.; Hosseini, G.; Sirrenberg, C.; Butler, G.S.; Crabbe, T.; Docherty, A.J.P.; Wiesner, M.; Murphy, G.; Overall, C.M.; Goodman, S.L.; Pepper, M.S. Dissecting the role of matrix metalloproteinases (MMP) and integrin αvβ3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but Membrane-Type 1-MMP and αvβ3 are critical. Cancer Res., 2005, 65, 9377-9387.
88. Tan, T.W.; Yang, W.H.; Lin, Y.T.; Hsu, S.F.; Li, T.M.; Kao, S.T.; Chen, W.C.; Fong, Y.C.; Tang, C.H. Cyr61 increases migration and MMP-13 expression via αvβ3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis, 2009, 30, 258-268.